Headwinds hit MedAdvisor revenue

The prescription management platform’s US arm has been hampered by difficult conditions, including low vaccine uptake and regulatory uncertainty, it told investors MedAdvisor’s US revenue has been clipped by lower pharmacy group spending in the US, as major chains face “financial distress”, its chair told the market. A few weeks ago, the company said John